list of analytical instruments used in pharmaceutical industry

List of Analytical Instruments Used in the Pharmaceutical Industry

admin 12 min read
List of Analytical Instruments Used in the Pharmaceutical Industry

Start with the analytical question

Analytical testing evaluates the identity, strength, purity, stability, and overall quality of pharmaceutical products. Those purposes give you a more useful starting point than an instrument catalogue because each category answers a different measurement question.

Analytical testing also helps confirm that released batches perform as intended and do not contain harmful levels of impurities or contaminants. The appropriate category depends on whether you need to separate components, identify molecules, assess a physical property, measure a process condition, or support a quality decision.

A practical pharmaceutical instrument map follows five questions:

  • What must you measure? Identity, concentration, purity, stability, particle distribution, a process parameter, or a quality attribute.
  • What is the sample? A finished product, active pharmaceutical ingredient, formulation, process stream, gas, solvent, or biological material.
  • Where will measurement occur? In a laboratory, near the process at-line, or directly in the process in-line.
  • What decision will the result support? Research and development, quality control, method development, release-related work, or process monitoring.
  • What performance is required? Sensitivity, precision, selectivity, sampling frequency, and compatibility with the operating environment.

The categories below are a non-exhaustive map rather than a universal purchasing list. Use the map to identify the analytical question first, then narrow the candidates.

Separation and composition instruments

Chromatography resolves individual analytes from multicomponent pharmaceutical samples. The category includes high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), gas chromatography (GC), headspace GC, thin-layer chromatography (TLC), and preparative chromatography.

Chromatographic separation is useful when a sample contains several components that must be distinguished before identification or quantification. HPLC and UPLC belong to the liquid-phase portion of this map, while GC and headspace GC address compounds that can be introduced into a gas chromatographic system. TLC and preparative chromatography serve different separation and development purposes. The instrument category should follow the chemical and sampling question, not the familiarity of the abbreviation.

Gas chromatography separates mixture components based on volatility and interaction with the column’s stationary phase. Gas chromatography therefore fits pharmaceutical questions involving volatile and semi-volatile compounds, where separation can precede identification and quantification.

Pharmaceutical GC applications include active pharmaceutical ingredient purity testing, residual-solvent analysis, stability testing, compound identification, method development, process optimization, metabolite analysis, impurity profiling, and chiral analysis. A GC shortlist should begin with the compound’s volatility and the intended result, then address the sample preparation and detector requirements needed for that result.

Chromatographic interpretation requires more than locating peaks.
Retention time alone seldom confirms identity, and adequate peak resolution alone does not establish fitness for the intended decision. For a method-development or quality-control question, define what constitutes identity, purity, or quantification before treating a separated peak as an answer. The separation is one part of the measurement chain.

Molecular identification through hyphenated methods

GC-MS combines gas-chromatographic separation with mass-spectrometric molecular identification based on mass-to-charge ratio for qualitative and quantitative analysis. This combination is suited to questions in which separating volatile or semi-volatile components is not enough and molecular characterization is also needed.

The gas chromatographic stage separates components, while the mass spectrometric stage supplies molecular information associated with each detected component. In pharmaceutical research, that distinction can matter when you are investigating an unknown, confirming a compound, or measuring a component within a complex mixture.

LC-MS combines liquid-chromatographic separation with mass-analysis precision and is useful for complex mixtures including pharmaceutical compounds. LC-MS offers sensitivity, selectivity, speed, and the ability to identify trace components within complex mixtures.

LC-MS belongs on a shortlist when the sample is better handled by liquid chromatography or when trace-component identification is central to the question. The combination does not remove the need to define the analyte, matrix, sample preparation, and intended decision. Those conditions determine whether the resulting molecular information answers the actual pharmaceutical problem.

The distinction between separation-only and hyphenated methods is a decision point:

  • Choose a separation category when resolving components and measuring their response addresses the question.
  • Investigate GC-MS when gas-phase separation and mass-based molecular identification belong together.
  • Investigate LC-MS when liquid-phase separation, complex mixtures, or trace-component identification define the problem.

Use the analytical objective to make the first cut. Treat the instrument name as a description of a measurement approach, not as the objective itself.

Checklist infographic for choosing hyphenated identification methods. It lists separation only, investigate GC-MS, and investigate LC-MS, with the conditions described for each choice.
Start with the analytical objective, then choose the measurement approach.

Spectroscopy and physical-property measurement

Spectroscopy is the most common analytical technique for Process Analytical Technology (PAT); Raman and Fourier transform infrared (FTIR) spectroscopy are often used for their sensitivity and speedy analysis. These methods place spectral information in the instrument map alongside chromatographic separation and mass-based identification.

A spectroscopy question usually begins with the chemical information sought from the sample and the setting in which the measurement will occur. You then need to determine whether the spectrum will be interpreted directly, compared with reference information, or used with a quantitative model. The answer affects the sample interface, calibration work, and evaluation conditions.

Particle-size analysis addresses a physical property rather than molecular identity. Particle size distribution testing may be performed in process when justified by product development data and may replace dissolution testing when development studies demonstrate that particle size is the primary factor influencing dissolution.

The qualification in that statement matters: particle-size testing does not automatically replace another test. The product-development evidence must show that particle size is the primary factor influencing dissolution, and the proposed use must fit the product context. For a solid dosage-form question, particle-size measurement may therefore belong on the shortlist when particle distribution is linked to the decision you need to make.

Spectroscopy and physical-property instruments answer different questions. Spectroscopy supplies chemical information, while particle-size measurement characterizes a distribution of physical dimensions. A pharmaceutical development team may investigate both categories for the same product, but the categories should not be treated as interchangeable substitutes without a defined analytical rationale.

Process monitoring and control

Process Analytical Technology (PAT) designs, analyzes, and controls pharmaceutical manufacturing processes by measuring critical process parameters that affect critical quality attributes. PAT therefore extends the instrument list from isolated laboratory tests to measurements connected with how a process operates.

The central question changes from “What is in this sample?” to “What process condition or quality attribute must be observed, and what decision will the result support?” That shift can change the measurement location, sampling frequency, data workflow, and requirements for integration with manufacturing operations.

That relationship gives PAT a useful internal logic. The measurement is not selected only because a sensor can detect a signal; it is selected because the signal relates to a critical process parameter or critical quality attribute and can support a defined manufacturing decision. In this framework, the process parameter is the variable being observed, while the quality attribute is the product-related result the process is intended to protect. Advanced analytics and data modeling help connect the sensor output with those parameters or attributes, and automation can use the resulting information for monitoring or control. This is why PAT evaluation must consider both analytical performance and the point at which the data will influence the process. A laboratory result may describe a sample accurately yet arrive too late for an in-line control decision; conversely, an in-line signal must be evaluated in its actual flow and access conditions.

PAT enables real-time, in-line monitoring and control of critical process parameters and critical quality attributes, supporting continuous manufacturing and Quality by Design initiatives. PAT combines advanced analytics, in-line sensors, data modeling, and automation to identify critical process parameters, improve product quality, reduce deviations, and support real-time release testing.

A process-monitoring shortlist should therefore identify the parameter or attribute, the point at which it must be observed, and the action associated with the result. A laboratory instrument may still be useful for reference measurements or development work, while an in-line approach may be needed when the process decision depends on observing a changing stream.

Process monitoring is a separate application lane within the broader pharmaceutical instrument map. The relevant category may be spectroscopy, another sensor-based measurement, or a combination of measurement and data analysis. Start with the process decision and the required observation conditions; then determine which instrument principle can produce the information at the necessary point in the workflow.

Flow infographic showing process parameters, in-line sensors, and data modeling converging into process monitoring. The result states that the combination supports real-time monitoring, control, and release decisions.
Begin with the process decision and required observation conditions.

Match testing to the pharmaceutical context

Test selection and acceptance criteria depend on the drug substance, manufacturing method, and intended use of the drug product. The same instrument category can therefore have different relevance across research, development, quality control, manufacturing, and product-specific testing.

Use the pharmaceutical context to narrow the list:

  • Drug substance and API work: Focus on identity, strength, purity, impurities, stability, or residual solvents as appropriate to the material and method.
  • Formulation and product development: Consider physical properties and product-performance questions alongside chemical composition.
  • Manufacturing control: Examine whether a laboratory, at-line, or in-line result can support the process decision and its timing.
  • Quality-control work: Define the result, reference method, precision, sensitivity, and acceptance criteria required for the intended use.
  • Special product conditions: Add tests associated with sterility, endotoxin, or other product-specific concerns only when the product context supports them.

This context prevents a broad catalogue from becoming an unsupported recommendation.

Context can also determine whether the relevant need is a conventional instrument category or a product-specific test. Sterility and endotoxin are not interchangeable versions of a general composition measurement: their relevance depends on whether the drug substance is manufactured as sterile or is used to formulate an injectable drug product. That makes the product context a screening step before instrument comparison. A useful sequence is to identify the material and intended use, state the decision the test must inform, and then determine whether the question concerns chemical composition, a physical property, a process parameter, or a product-specific condition. Only after that sequence should you compare methods, reference measurements, sensitivity, precision, or acceptance criteria. This prevents the category list from implying that one analytical technique can address every pharmaceutical quality question.

Sterility testing may be appropriate for sterile drug substances, and endotoxin testing may be appropriate for drug substances used in injectable products. These examples show why the product and intended use must remain visible when you compare instrument categories.

Do not treat a general list as a determination that a particular test is required. Define the material, manufacturing method, intended use, and decision first, then examine the applicable analytical method and operating conditions.

Organize analytical instruments by pharmaceutical measurement need

Begin with the pharmaceutical measurement need, not a product label. The relevant category depends on whether the task is separating mixture components, identifying molecules, measuring chemical information or physical properties, or monitoring process parameters and quality attributes. Matrix, sensitivity, precision, and the laboratory, at-line, or in-line setting then clarify which categories merit further technical evaluation.

The map below organizes the selected categories by analytical purpose and connects each with its pharmaceutical measurement role.

Measurement setting Main question Conditions to define before evaluation
Laboratory Can the method produce the required result from a controlled sample? Sample preparation, matrix representation, reference method, sensitivity, and precision
At-line Can a measurement near the process provide a timely result from a defined sample path? Sampling frequency, transfer and handling, sample stability, operator steps, and process timing
In-line Can the connected measurement observe a changing stream closely enough to support the intended decision? Installation point, flow and process conditions, representative access, model domain, data handling, and maintenance

Use the category map to interpret results before comparing methods. GC-MS and LC-MS add molecular identification to separation, whereas spectroscopy, particle-size testing, and PAT address different chemical, physical, and process questions.

The measurement setting determines the conditions for evaluation. For laboratory work, define sample preparation, matrix representation, reference method, sensitivity, and precision. For at-line work, define sampling frequency, transfer and handling, sample stability, operator steps, and process timing. For in-line work, define the installation point, flow and process conditions, representative access, model domain, data handling, and maintenance. For a quantitative spectroscopic or modeled measurement, the calibration set must span the expected concentration range, including the extremes.

Prepare quantitative evaluations with representative evidence

A quantitative spectroscopic evaluation depends on calibration samples that represent the concentrations the method is expected to encounter. Our calibration set must span the range of expected concentrations, including the extremes.

That condition applies when a model is used to turn a measured signal into a concentration estimate. Before comparing a modeled instrument with another analytical category, define the expected range, include its boundaries in the evaluation set, and connect the model output to a reference method. A collection of convenient samples is not the same as a set that represents the intended operating range.

Use a short preparation checklist:

  • State the concentration or process range that the measurement must cover.
  • Include samples at the expected low and high extremes.
  • Identify the reference method used to establish the target values.
  • Separate the recorded measurement from the calculated concentration or process attribute.
  • Test whether the evaluation samples represent the matrix and operating conditions of the intended use.

The checklist organizes an evaluation. It does not establish suitability by itself; the proposed use still determines the required evidence and review.

Use supplier examples only after defining the need

OrionIR® is a supplier-specific example within the broader spectroscopy category, not a replacement for the category map. We use the OrionIR® to determine what is in the liquid and how much.

That stated role places OrionIR® in questions involving liquid composition and concentration. The instrument should enter your shortlist only after you have defined the analyte, matrix, measurement objective, required sensitivity, precision, and measurement setting.

Our OrionIR® is a mid-IR spectrometer that provides one spectrum every second across 900–3500 cm⁻¹ through aqueous, strongly absorbing, and low-concentration streams. These are the stated operating characteristics to examine against a specific pharmaceutical stream; they are not a general determination that the instrument fits every liquid measurement.

A useful comparison asks whether the described spectral range, sampling interval, and stream conditions correspond to the chemistry and decision you have already defined. The comparison should also address sample access, calibration coverage, and the difference between an observed spectrum and the quantitative result derived from it.

Paeonia Innovations asks customers to describe the stream and chemistry so we can determine OrionIR® compatibility and configuration. We offer to test the OrionIR® on customer process samples when it makes sense.

We can also supply basic reference spectra for common solvents including ethanol, acetone, IPA, methanol, acetonitrile, and toluene. These supplier-specific steps are useful after the measurement question has been defined: prepare the stream description, chemistry, concentration range, operating context, and intended result so the technical discussion has a clear basis.

Supplier information belongs at the end of the narrowing process. First identify the pharmaceutical measurement category; next define the sample and decision; then compare the documented configuration with those conditions. This order keeps a product example secondary to the analytical requirement.

StatRow infographic showing the OrionIR spectral range from 900 cm⁻¹ to 3500 cm⁻¹. It draws the lower and upper ends of the stated operating range.
The documented spectral range should be compared with the defined chemistry and decision.

Know when to seek qualified review

Qualified technical or regulatory review belongs in the decision path when a proposed measurement will inform release, sterility or endotoxin decisions, process control, or an in-line deployment. Seek that review when the measurement evidence, sampling conditions, reference method, model domain, data handling, or operating requirements remain unclear.

Pause the shortlist rather than treating an unresolved condition as a minor implementation detail. Record the unresolved question, the decision it could affect, and the technical information needed to evaluate it.

Pharmaceutical teams operating across North America, South America, Europe, or Asia may also need to account for local facility conditions, quality systems, and regulatory expectations. Classified areas, continuous manufacturing arrangements, and site-specific operating controls can change the practical requirements for an instrument or measurement workflow.

Use qualified review to connect the analytical category with the intended site, process, and decision. A broad instrument list cannot make that determination on its own.

Create the next-step shortlist

A useful pharmaceutical instrument shortlist connects one measurement question to one or more candidate categories and records the conditions that could change the decision. Before moving forward, prepare these details:

  • The analyte, quality attribute, or process parameter.
  • The sample matrix, expected concentration range, and relevant physical form.
  • The analytical objective, such as identification, quantification, impurity assessment, particle-size characterization, or process monitoring.
  • The required sensitivity, precision, sampling frequency, and measurement setting.
  • The intended pharmaceutical context, including research, development, quality control, manufacturing, or a product-specific test.
  • The reference method, operating environment, and unresolved technical questions.

A qualified professional should decide whether a proposed method is suitable for your specific release, process-control, sterility, endotoxin, or installation decision. Send the stream, chemistry, measurement objective, and operating context so the team can discuss the technical question on defined terms.



Next step

Have a question for Paeonia Innovations?

Get in touch